![Kirsten Flowers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirsten Flowers
Direktör/Styrelseledamot på
PMV PHARMACEUTICALS, INC.
Förmögenhet: - $ per 2026-07-31
Profil
Kirsten Flowers is currently an Independent Director at PMV Pharmaceuticals, Inc. since 2022 and a Director at Comera Life Sciences, Inc. Former roles include Independent Director at Comera Life Sciences Holdings, Inc., Senior Vice President-Commercial Operations at Array BioPharma, Inc. from 2017 to 2019, and Chief Commercial & Strategy Officer at Kura Oncology, Inc. from 2020 to 2023.
Education includes an undergraduate degree from the University of Arizona and an MBA from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-04 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Kirsten Flowers
| Företag | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2022-01-05 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Kirsten Flowers
| Företag | Position | Slut |
|---|---|---|
| KURA ONCOLOGY, INC. | Företagsledare/Principal | 2023-01-27 |
| ARRAY TECHNOLOGIES, INC. | Företagsledare/Principal | 2019-01-01 |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Direktör/Styrelseledamot | - |
Kirsten Flowerss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
49
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
